Is Hematopoietic Stem Cell the only APDS Option? Other 10 Mins Read0 APDS or activated PI3KK delta syndrome is a relatively new disease that was only fully characterized in 2013. It is…
Momelotinib a JAK inhibitor vs Danazol in Myelofibrosis Myeloproliferative Disease 14 Mins Read4 Momelotinib Shows Promising JAK and ALK2 Inhabitation in Patients With Anemic Myelofibrosis: MOMENTUM Study It’s my pleasure today to discuss…
